Farms.com Home   Ag Industry News

Alliance Grain Traders Buys Québec Food Firm

By Amanda Brodhagen, Farms.com

Alliance Grain Traders Inc. (AGT), one of the world’s largest processors of pulses, said that it has agreed to acquire Québec-based CLIC International Inc., an ethnic and traditional food packer.

AGT said that the acquisition includes inventory, retail packaging and canning equipment, CLIC and retail brands, retail and food service listings and customer contracts. The CLIC management staff will also remain with AGT.

"The acquisition of CLIC bolsters our Ingredient and Packaged Foods business segment, with small packaging and canning lines to distribute a broad line of pulses and ethnic foods to the North American and global retail and food service sectors,” said Murad Al-Katib, President and Chief Executive Officer of AGT.

Al-Katib said the transaction will further AGT’s objective to transition from a commodity exporter to a food company. The terms of the deal were not disclosed.
 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.